BK Virus-Associated Nephropathy after Renal Transplantation

Area of Science:

• Nephrology
• Virology
• Transplantation Immunology

Background:

• Advances in immunosuppression improve renal transplant outcomes but increase risks.
• BK virus nephropathy is a leading cause of graft dysfunction post-transplantation.
• Progression from BK viruria to viremia and nephropathy necessitates early detection.

Purpose of the Study:

• To review screening and diagnostic methods for BK virus associated nephropathy.
• To discuss pathological classifications and treatment strategies.
• To highlight controversies in managing BK virus nephropathy in renal transplant patients.

Main Methods:

• Review of screening tests: urinary cytology, urinary and plasma PCR.
• Histological confirmation: tubulointerstitial inflammation, intranuclear inclusions, SV40 T-antigen immunostaining.
• Analysis of proposed pathological classifications for disease severity.

Main Results:

• Histology remains the gold standard for diagnosing BK virus associated nephropathy.
• No specific antiviral therapies exist; immunosuppression reduction is the primary treatment.
• Management strategies, including rejection diagnosis and immunosuppression resumption, lack consensus.

Conclusions:

• Early detection and accurate diagnosis of BK virus nephropathy are vital for graft survival.
• Current treatment relies on reducing immunosuppression, with ongoing debates on optimal protocols.
• Further research is needed to standardize management and improve long-term outcomes.